Marie-Aleth Richard
Prof Marie-Aleth Richard is an expert in Dermatology at Hôpital de la Timone (France). As of October 2026, ScienceLeadR ranks Marie-Aleth Richard in the top 1% of experts worldwide for Sexually Transmitted Diseases, Psoriasis and Dermatitis. Marie-Aleth Richard has authored 634 publications, the most recent in 2026, and is an investigator in 19 clinical trials, 6 of them ongoing. SLR score: 1,933 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Infectiology - Public Health - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1986 - 2026
Number : 634
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 19
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
6 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| FEcal tranSplantation in HidradeniTIs suppuratiVA a piLot Study NCT07668713 — pilot projects, pilots, fecal microbiota transplantation, hidradenitis suppurativa, hidradenitis, therapeutics, transplantation, microbiota | Phase 1 | Not yet recruiting | 2026 |
| Involvement of Pollutants in Atopic Dermatitis and Psoriasis NCT06213688 — cytokines, cells, receptors, aryl hydrocarbon, dioxins, t-lymphocytes, regulatory, blood, dermatitis, environmental pollutants, eczema, benzo(a)pyrene, environmental pollution, polycyclic aromatic hydrocarbons, hydrocarbons, psoriasis, hydrocarbons, aromatic, dermatitis, atopic | N/A | Not yet recruiting | 2024 |
| Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus NCT05898308 — injections, skin, antibodies, adrenal cortex hormones, skin diseases, desmogleins, biomarkers, maintenance, rituximab, precision medicine, acantholysis, therapeutics, pemphigus | Phase 4 | Recruiting | 2024 |
| Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis NCT04789850 — sclerosis, safety, scleroderma, systemic | Phase 2 | Recruiting | 2023 |
| Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis NCT04227314 — stomatitis, aphthous, safety, tablets, stomatitis, therapeutics | Phase 3 | Recruiting | 2022 |
LeadR Networks
Main global connection map